We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+19.09%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.27B
AUM Growth
-$5.76B
Cap. Flow
-$1.51B
Cap. Flow %
-46.09%
Top 10 Hldgs %
34.23%
Holding
5,681
New
749
Increased
1,274
Reduced
3,081
Closed
446

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$99.8M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$86.3M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$48M
4
IWB icon
iShares Russell 1000 ETF
IWB
+$23M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.3M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$36.3M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$31.4M
3
AAPL icon
Apple
AAPL
+$30.2M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.6M
5
MSFT icon
Microsoft
MSFT
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Financials 8.46%
3 Healthcare 8.24%
4 Consumer Discretionary 7.74%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVAN.U
4076
DELISTED
Avanti Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
AVAN.U
$15K ﹤0.01%
+1,406
New +$14.3K
RESN
4077
DELISTED
Resonant Inc.
RESN
$15K ﹤0.01%
5,551
-42,698
-88% -$101K
PFIN
4078
DELISTED
P&F Industries
PFIN
$15K ﹤0.01%
2,560
+1,853
+262% +$9.01K
ABCL icon
4079
AbCellera Biologics
ABCL
$2.99B
$14K ﹤0.01%
+354
New +$16.2K
ADAP
4080
DELISTED
Adaptimmune Therapeutics
ADAP
$14K ﹤0.01%
+2,683
New +$14.6K
AIRG icon
4081
Airgain
AIRG
$70M
$14K ﹤0.01%
774
+138
+22% +$1.92K
ALGS icon
4082
Aligos Therapeutics
ALGS
$45.5M
$14K ﹤0.01%
+20
New +$9.74K
AOD
4083
abrdn Total Dynamic Dividend Fund
AOD
$1.13B
$14K ﹤0.01%
+1,550
New +$12.9K
ARL icon
4084
American Realty Investors
ARL
$246M
$14K ﹤0.01%
1,318
-383
-23% -$3.81K
ARMP icon
4085
Armata Pharmaceuticals
ARMP
$156M
$14K ﹤0.01%
4,674
+2,404
+106% +$7.64K
LONA
4086
LeonaBio Inc
LONA
$71.6M
$14K ﹤0.01%
+41
New +$9.67K
AUTL
4087
Autolus Therapeutics
AUTL
$620M
$14K ﹤0.01%
1,612
-3,591
-69% -$38.3K
AVIR icon
4088
Atea Pharmaceuticals
AVIR
$404M
$14K ﹤0.01%
+332
New +$10.7K
BRZU icon
4089
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$90M
$14K ﹤0.01%
117
-242
-67% -$21.7K
CIX icon
4090
Comp X International
CIX
$388M
$14K ﹤0.01%
964
-945
-50% -$13.1K
FDUS icon
4091
Fidus Investment
FDUS
$752M
$14K ﹤0.01%
1,070
-2,530
-70% -$30.1K
GYRE icon
4092
Gyre Therapeutics
GYRE
$704M
$14K ﹤0.01%
298
-2,145
-88% -$92.9K
HCI icon
4093
HCI Group
HCI
$2.29B
$14K ﹤0.01%
275
-5,760
-95% -$291K
HQI icon
4094
HireQuest
HQI
$239M
$14K ﹤0.01%
1,374
+162
+13% +$1.39K
HYLS icon
4095
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.64B
$14K ﹤0.01%
+293
New +$14.1K
IBEX icon
4096
IBEX
IBEX
$491M
$14K ﹤0.01%
745
-201
-21% -$3.58K
IHG icon
4097
InterContinental Hotels
IHG
$23B
$14K ﹤0.01%
214
-2,721
-93% -$160K
INTG icon
4098
InterGroup Corp
INTG
$71.8M
$14K ﹤0.01%
446
+138
+45% +$4.52K
KROS icon
4099
Keros Therapeutics
KROS
$211M
$14K ﹤0.01%
192
-6,207
-97% -$391K
MAPS
4100
DELISTED
WM TECHNOLOGY INC A
MAPS
$14K ﹤0.01%
+1,098
New +$11.8K
162 163
164
165 166

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2020 Portfolio in Review

As of Q4 2020, Tower Research Capital (TRC) held 5,681 positions worth $3.27B, down 64% from $9.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.51B in Q4 2020, closing 446 positions and reducing 3,081 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 6.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2020 buy was iShares Russell 1000 ETF: 115,321 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $99.8M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $36.3M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q4 2020, selling an estimated $13.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $3.27B portfolio in Q4 2020.
  • Tower Research Capital (TRC) opened 749 new positions and closed 446 in Q4 2020.
  • Tower Research Capital (TRC)'s portfolio value fell 64% quarter-over-quarter to $3.27B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.